| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 1.12e-04 | 3 | 123 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 1.12e-04 | 3 | 123 | 2 | GO:0019118 | |
| Domain | IPT | 2.89e-05 | 27 | 124 | 4 | SM00429 | |
| Domain | ASH | 4.37e-05 | 2 | 124 | 2 | IPR031549 | |
| Domain | ASH | 4.37e-05 | 2 | 124 | 2 | PF15780 | |
| Domain | TIG | 5.07e-05 | 31 | 124 | 4 | PF01833 | |
| Domain | IPT | 5.76e-05 | 32 | 124 | 4 | IPR002909 | |
| Domain | HEAT_REPEAT | 1.02e-04 | 70 | 124 | 5 | PS50077 | |
| Domain | NMDAR2_C | 1.31e-04 | 3 | 124 | 2 | PF10565 | |
| Domain | NMDAR2_C | 1.31e-04 | 3 | 124 | 2 | IPR018884 | |
| Domain | DUF1605 | 1.81e-04 | 17 | 124 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 1.81e-04 | 17 | 124 | 3 | PF07717 | |
| Domain | HA2 | 2.17e-04 | 18 | 124 | 3 | SM00847 | |
| Domain | HA2 | 2.17e-04 | 18 | 124 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 2.17e-04 | 18 | 124 | 3 | IPR007502 | |
| Domain | HEAT | 2.87e-04 | 48 | 124 | 4 | PF02985 | |
| Domain | Munc13_dom-2 | 4.32e-04 | 5 | 124 | 2 | IPR014772 | |
| Domain | MHD2 | 4.32e-04 | 5 | 124 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 4.32e-04 | 5 | 124 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 4.32e-04 | 5 | 124 | 2 | PF10540 | |
| Domain | ARM-type_fold | 4.38e-04 | 339 | 124 | 9 | IPR016024 | |
| Domain | - | 4.64e-04 | 148 | 124 | 6 | 2.60.40.150 | |
| Domain | HEAT | 5.95e-04 | 58 | 124 | 4 | IPR000357 | |
| Domain | C2_dom | 7.96e-04 | 164 | 124 | 6 | IPR000008 | |
| Domain | Munc13_1 | 8.98e-04 | 7 | 124 | 2 | IPR014770 | |
| Domain | MHD1 | 8.98e-04 | 7 | 124 | 2 | PS51258 | |
| Domain | DUF1041 | 8.98e-04 | 7 | 124 | 2 | PF06292 | |
| Domain | CAPS_dom | 8.98e-04 | 7 | 124 | 2 | IPR010439 | |
| Domain | C1 | 9.17e-04 | 65 | 124 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 9.71e-04 | 66 | 124 | 4 | IPR002219 | |
| Domain | Semap_dom | 1.12e-03 | 31 | 124 | 3 | IPR001627 | |
| Domain | SEMA | 1.12e-03 | 31 | 124 | 3 | PS51004 | |
| Domain | Sema | 1.12e-03 | 31 | 124 | 3 | SM00630 | |
| Domain | Sema | 1.12e-03 | 31 | 124 | 3 | PF01403 | |
| Domain | Plexin_repeat | 1.23e-03 | 32 | 124 | 3 | IPR002165 | |
| Domain | PSI | 1.23e-03 | 32 | 124 | 3 | PF01437 | |
| Domain | IQ | 1.28e-03 | 71 | 124 | 4 | PF00612 | |
| Domain | Plexin_cytopl | 1.53e-03 | 9 | 124 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.53e-03 | 9 | 124 | 2 | IPR013548 | |
| Domain | Plexin | 1.53e-03 | 9 | 124 | 2 | IPR031148 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.60e-03 | 35 | 124 | 3 | IPR002464 | |
| Domain | C2 | 1.82e-03 | 131 | 124 | 5 | PF00168 | |
| Domain | DEAH_ATP_HELICASE | 2.03e-03 | 38 | 124 | 3 | PS00690 | |
| Domain | IQ | 2.08e-03 | 81 | 124 | 4 | SM00015 | |
| Domain | ARM-like | 2.19e-03 | 270 | 124 | 7 | IPR011989 | |
| Domain | C2 | 2.21e-03 | 137 | 124 | 5 | SM00239 | |
| Domain | C2 | 2.58e-03 | 142 | 124 | 5 | PS50004 | |
| Domain | IQ_motif_EF-hand-BS | 3.05e-03 | 90 | 124 | 4 | IPR000048 | |
| Domain | PSI | 3.10e-03 | 44 | 124 | 3 | IPR016201 | |
| Domain | IQ | 3.43e-03 | 93 | 124 | 4 | PS50096 | |
| Domain | PSI | 3.52e-03 | 46 | 124 | 3 | SM00423 | |
| Domain | - | 3.68e-03 | 222 | 124 | 6 | 1.25.10.10 | |
| Domain | IMPORTIN_B_NT | 3.78e-03 | 14 | 124 | 2 | PS50166 | |
| Domain | Ig_E-set | 5.11e-03 | 104 | 124 | 4 | IPR014756 | |
| Domain | NADP_OxRdtase_dom | 5.57e-03 | 17 | 124 | 2 | IPR023210 | |
| Domain | Importin-beta_N | 5.57e-03 | 17 | 124 | 2 | IPR001494 | |
| Domain | Aldo_ket_red | 5.57e-03 | 17 | 124 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 5.57e-03 | 17 | 124 | 2 | IPR001395 | |
| Domain | ZnF_C2HC | 5.83e-03 | 55 | 124 | 3 | SM00343 | |
| Domain | Znf_CCHC | 5.83e-03 | 55 | 124 | 3 | IPR001878 | |
| Domain | Lig_chan-Glu_bd | 6.24e-03 | 18 | 124 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.24e-03 | 18 | 124 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.24e-03 | 18 | 124 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 6.24e-03 | 18 | 124 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.24e-03 | 18 | 124 | 2 | IPR001508 | |
| Domain | Lig_chan | 6.24e-03 | 18 | 124 | 2 | PF00060 | |
| Domain | PBPe | 6.24e-03 | 18 | 124 | 2 | SM00079 | |
| Domain | C1_1 | 6.44e-03 | 57 | 124 | 3 | PF00130 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | KIF23 RPS5 KDM3B ANKHD1 DHX9 GMPS SF3B1 BRCA2 MKI67 EHMT1 CCT8 SLX4IP SLX4 KPNB1 | 7.53e-11 | 357 | 129 | 14 | 37059091 |
| Pubmed | IPO5 KIF23 MYO1D RPS5 PSMC2 DHX57 RPS23 ANKHD1 GMPS URB1 SF3B1 MKI67 SMARCC2 UTP20 VCL KPNB1 | 2.98e-09 | 653 | 129 | 16 | 22586326 | |
| Pubmed | 1.09e-08 | 73 | 129 | 7 | 22094256 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC KIF23 RPS5 PSMC2 DHX57 RPS23 ANKHD1 DHX9 GMPS URB1 SF3B1 CPNE3 MKI67 ASPM CCT8 SMARCC2 UTP20 WDFY3 DHX29 VCL KPNB1 | 2.81e-08 | 1353 | 129 | 21 | 29467282 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYC KIF23 USP28 RPS5 CYP51A1 PSMC2 RPS23 DHX9 URB1 SF3B1 KLF10 MKI67 NFYC CCT8 SMARCC2 UTP20 VCL KPNB1 | 2.88e-08 | 989 | 129 | 18 | 36424410 |
| Pubmed | IPO5 KIF23 RPS5 PSMC2 RPS23 DHX9 GMPS SF3B1 MKI67 CCT8 SMARCC2 VCL KPNB1 | 4.32e-08 | 494 | 129 | 13 | 26831064 | |
| Pubmed | 1.77e-07 | 225 | 129 | 9 | 12168954 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.55e-07 | 235 | 129 | 9 | 30258100 | |
| Pubmed | MYC KIF23 MYO1D RPS5 PSMC2 RELA SMG5 ANKHD1 KMT2C KLF10 BANP MKI67 NFYC EHMT1 SLX4IP SMARCC2 N4BP1 VGLL4 SLX4 VCL | 3.27e-07 | 1429 | 129 | 20 | 35140242 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 6.77e-07 | 264 | 129 | 9 | 32814769 | |
| Pubmed | IPO5 CDC42BPG PNKP KIF23 MYO1D RPS5 PSMC2 RPS23 MED13L DHX9 GMPS SF3B1 MKI67 CCT8 SMARCC2 CDH3 VCL KPNB1 | 8.70e-07 | 1247 | 129 | 18 | 27684187 | |
| Pubmed | MYC KIF23 USP28 MED13L SF3B1 FAM111A BRCA2 TONSL SLX4IP SMARCC2 SLX4 | 1.09e-06 | 453 | 129 | 11 | 29656893 | |
| Pubmed | IPO5 KIF23 ZFYVE16 RPS5 CYP51A1 KDM3B PSMC2 RPS23 ANKHD1 DHX9 AKR7A2 GMPS SF3B1 MKI67 EHMT1 CCT8 SMARCC2 KPNB1 | 1.52e-06 | 1297 | 129 | 18 | 33545068 | |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 15964792 | ||
| Pubmed | Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice. | 1.73e-06 | 7 | 129 | 3 | 36897941 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | KIF23 ZFYVE16 USP28 KDM3B PSMC2 RPS23 ANKHD1 GMPS SF3B1 CPNE3 MKI67 CCT8 DHX29 VCL KPNB1 | 2.12e-06 | 934 | 129 | 15 | 33916271 |
| Pubmed | Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. | 2.75e-06 | 8 | 129 | 3 | 19427292 | |
| Pubmed | 3.27e-06 | 61 | 129 | 5 | 20305087 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UNC13B PLXNA3 KDM3B SMG5 MED13L ANKHD1 MST1R PLEKHG1 KMT2C URB1 KLF10 BANP EHMT1 WDFY3 ELL GAREM1 | 3.58e-06 | 1105 | 129 | 16 | 35748872 |
| Pubmed | 4.59e-06 | 250 | 129 | 8 | 33536335 | ||
| Pubmed | MYC IPO5 PNKP KIF23 USP28 KDM3B MED13L DHX9 GMPS SF3B1 CPNE3 MKI67 EHMT1 CCT8 SMARCC2 | 5.71e-06 | 1014 | 129 | 15 | 32416067 | |
| Pubmed | 8.05e-06 | 11 | 129 | 3 | 38199563 | ||
| Pubmed | Large-scale genotyping identifies 41 new loci associated with breast cancer risk. | 9.71e-06 | 76 | 129 | 5 | 23535729 | |
| Pubmed | SLC25A21 TUT4 RBL2 ITPRID1 ANKHD1 PTPRZ1 LMLN SSX2IP PAN2 ELMOD3 DHX29 HYDIN | 1.01e-05 | 686 | 129 | 12 | 29987050 | |
| Pubmed | PNKP ZFYVE16 KDM3B PSMC2 CBLB MTMR10 SF3B1 KLF10 ZNF587 VCL KPNB1 | 1.36e-05 | 591 | 129 | 11 | 15231748 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25131300 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19224914 | ||
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 1.37e-05 | 2 | 129 | 2 | 20921396 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 1.37e-05 | 2 | 129 | 2 | 16901514 | |
| Pubmed | Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. | 1.37e-05 | 2 | 129 | 2 | 22726846 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 20696923 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 23618906 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19474217 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12027803 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 1.37e-05 | 2 | 129 | 2 | 26179233 | |
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 1.37e-05 | 2 | 129 | 2 | 16033900 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 38214768 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21503117 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 18372311 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 32247039 | ||
| Pubmed | NF-κB downregulates Cbl-b through binding and suppressing Cbl-b promoter in T cell activation. | 1.37e-05 | 2 | 129 | 2 | 25762784 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 32606037 | ||
| Pubmed | Separate functional properties of NMDARs regulate distinct aspects of spatial cognition. | 1.37e-05 | 2 | 129 | 2 | 29764972 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27605622 | ||
| Pubmed | Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function. | 1.37e-05 | 2 | 129 | 2 | 33043365 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 30355491 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12127670 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 20890276 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16045501 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27915379 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 32179753 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16944113 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 9822733 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 18623111 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15355351 | ||
| Pubmed | NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. | 1.37e-05 | 2 | 129 | 2 | 15742215 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10446203 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 37657442 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 38813758 | ||
| Pubmed | Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease. | 1.37e-05 | 2 | 129 | 2 | 38731978 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 30269991 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 31498792 | ||
| Pubmed | Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons. | 1.37e-05 | 2 | 129 | 2 | 32191258 | |
| Pubmed | Distinct roles of GRIN2A and GRIN2B variants in neurological conditions. | 1.37e-05 | 2 | 129 | 2 | 31807283 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26500840 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27015584 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26365176 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19806658 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22142193 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 33976221 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22334046 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25283079 | ||
| Pubmed | ELL targets c-Myc for proteasomal degradation and suppresses tumour growth. | 1.37e-05 | 2 | 129 | 2 | 27009366 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 34197904 | ||
| Pubmed | Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. | 1.37e-05 | 2 | 129 | 2 | 16157280 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 34830255 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 29069077 | ||
| Pubmed | NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease. | 1.37e-05 | 2 | 129 | 2 | 36232696 | |
| Pubmed | Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors. | 1.37e-05 | 2 | 129 | 2 | 22306487 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 36038077 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 20211864 | ||
| Pubmed | Evolution of GluN2A/B cytoplasmic domains diversified vertebrate synaptic plasticity and behavior. | 1.37e-05 | 2 | 129 | 2 | 23201971 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11719203 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16266783 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 27839871 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10212223 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22187052 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17569088 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11530236 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 18197970 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 32866686 | ||
| Pubmed | Crybb2 coding for βB2-crystallin affects sensorimotor gating and hippocampal function. | 1.39e-05 | 13 | 129 | 3 | 24096375 | |
| Pubmed | 1.39e-05 | 13 | 129 | 3 | 25450615 | ||
| Pubmed | 1.39e-05 | 383 | 129 | 9 | 29331416 | ||
| Pubmed | KIF23 CTTNBP2 USP28 TRIOBP SIRPB1 GRIN2A GRIN2B MDK SF3B1 EHMT1 CCT8 SMARCC2 WDFY3 KPNB1 | 1.45e-05 | 963 | 129 | 14 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TUT4 MYO1D TRIOBP DHX57 SMG5 ANKHD1 URB1 MKI67 EHMT1 CCT8 DHX29 VCL | 1.72e-05 | 724 | 129 | 12 | 36232890 |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 1.75e-05 | 217 | 129 | 7 | 31685992 | |
| Pubmed | 1.76e-05 | 14 | 129 | 3 | 32249816 | ||
| Pubmed | 1.76e-05 | 14 | 129 | 3 | 36305367 | ||
| Interaction | BRCA1 interactions | MYC IPO5 KIF23 RBL2 USP28 RPS5 PSMC2 RELA RPS23 DHX9 GMPS SF3B1 FAM111A BRCA2 SSX2IP TONSL MKI67 CCT8 SLX4IP SMARCC2 SLX4 VCL KPNB1 | 2.32e-06 | 1249 | 125 | 23 | int:BRCA1 |
| Interaction | SLX4 interactions | KIF23 RPS5 KDM3B ANKHD1 DHX9 GMPS SF3B1 BRCA2 MKI67 EHMT1 CCT8 SLX4IP SLX4 ELL KPNB1 | 2.66e-06 | 572 | 125 | 15 | int:SLX4 |
| Interaction | SPDL1 interactions | MYC IPO5 TUT4 CTTNBP2 RPS5 RPS23 DHX9 SF3B1 CPNE3 SLX4 KPNB1 | 4.35e-06 | 315 | 125 | 11 | int:SPDL1 |
| Interaction | TERF2IP interactions | MYC KIF23 ARPP21 USP28 KDM3B BRCA2 BANP CPNE3 MKI67 SLX4IP SMARCC2 VGLL4 WDFY3 SLX4 | 8.56e-06 | 552 | 125 | 14 | int:TERF2IP |
| Interaction | CCNE1 interactions | 1.05e-05 | 121 | 125 | 7 | int:CCNE1 | |
| Interaction | SIRT7 interactions | IPO5 KIF23 MYO1D RPS5 PSMC2 DHX57 RPS23 ANKHD1 GMPS URB1 SF3B1 MKI67 SMARCC2 UTP20 VCL KPNB1 | 1.49e-05 | 744 | 125 | 16 | int:SIRT7 |
| Interaction | GSK3B interactions | MYC IPO5 DENND4A PSMC2 TRIOBP RELA GMPS PPARGC1A SF3B1 SSX2IP TONSL CPNE3 MKI67 CCT8 SLX4 VCL KPNB1 | 2.61e-05 | 868 | 125 | 17 | int:GSK3B |
| Interaction | ACTC1 interactions | MYC KIF23 MYO1D RPS5 KDM3B GRIN2B SF3B1 MKI67 ASPM PAN2 CCT8 SMARCC2 SLX4 VCL KPNB1 | 2.65e-05 | 694 | 125 | 15 | int:ACTC1 |
| Interaction | CALM1 interactions | MYC UNC13B DENND4A KIF23 ARPP21 MYO1D KDM3B RELA IQCN GRIN2B MYO3A SF3B1 ASPM PAN2 | 3.46e-05 | 626 | 125 | 14 | int:CALM1 |
| Interaction | RPL35 interactions | MYC IPO5 KIF23 RPS5 PSMC2 RPS23 MDK MST1R SF3B1 FAM111A PAN2 CCT8 KPNB1 | 4.41e-05 | 558 | 125 | 13 | int:RPL35 |
| Interaction | NPM1 interactions | MYC IPO5 KIF23 RPS5 DHX57 RELA RPS23 MDK DHX9 URB1 FAM111A BRCA2 BANP MKI67 ASPM NFYC PAN2 RP1 DHX29 SLX4 | 4.88e-05 | 1201 | 125 | 20 | int:NPM1 |
| Interaction | REV1 interactions | 6.36e-05 | 35 | 125 | 4 | int:REV1 | |
| Interaction | DYNLL1 interactions | MYC CDC42BPG KIF23 CTTNBP2 USP28 RPS5 KMT2C SSX2IP PAN2 TRAF3IP3 ELL MORN3 | 8.01e-05 | 510 | 125 | 12 | int:DYNLL1 |
| Interaction | CALML3 interactions | 9.53e-05 | 230 | 125 | 8 | int:CALML3 | |
| Interaction | TOP3B interactions | UNC13B IPO5 PLXNA3 KIF23 MYO1D KDM3B DHX57 SMG5 MED13L ANKHD1 DHX9 MST1R PLEKHG1 KMT2C URB1 KLF10 SSX2IP BANP EHMT1 WDFY3 ELL GAREM1 | 9.61e-05 | 1470 | 125 | 22 | int:TOP3B |
| Interaction | RPS6 interactions | MYC KIF23 RPS5 PSMC2 DHX57 RPS23 DHX9 URB1 FAM111A MKI67 PAN2 UTP20 DHX29 SLX4 VCL KPNB1 | 1.02e-04 | 874 | 125 | 16 | int:RPS6 |
| Interaction | POLDIP3 interactions | 1.17e-04 | 237 | 125 | 8 | int:POLDIP3 | |
| Interaction | TP63 interactions | 1.19e-04 | 304 | 125 | 9 | int:TP63 | |
| Interaction | SLFN11 interactions | 1.20e-04 | 376 | 125 | 10 | int:SLFN11 | |
| Interaction | NCL interactions | MYC KIF23 RPS5 PSMC2 RPS23 MDK FAM90A27P DHX9 ENAM PPARGC1A BRCA2 PTPRZ1 PAN2 SLX4 KPNB1 | 1.28e-04 | 798 | 125 | 15 | int:NCL |
| Interaction | AR interactions | MYC CDC42BPG MYO1D USP28 RPS5 KDM3B PSMC2 RELA RPS23 MED13L DHX9 GMPS KMT2C SF3B1 TONSL CPNE3 SMARCC2 | 1.35e-04 | 992 | 125 | 17 | int:AR |
| Interaction | RAD21 interactions | 1.42e-04 | 384 | 125 | 10 | int:RAD21 | |
| Interaction | NSMCE2 interactions | 1.44e-04 | 43 | 125 | 4 | int:NSMCE2 | |
| Interaction | KCTD7 interactions | 1.49e-04 | 81 | 125 | 5 | int:KCTD7 | |
| Interaction | YTHDF3 interactions | 1.52e-04 | 246 | 125 | 8 | int:YTHDF3 | |
| Interaction | TMOD2 interactions | 1.58e-04 | 82 | 125 | 5 | int:TMOD2 | |
| Interaction | ZBTB7A interactions | 1.68e-04 | 131 | 125 | 6 | int:ZBTB7A | |
| Interaction | RPL19 interactions | MYC KIF23 RPS5 DHX57 RPS23 DHX9 GMPS MST1R SF3B1 FAM111A MKI67 PAN2 SLX4 | 1.69e-04 | 638 | 125 | 13 | int:RPL19 |
| Interaction | FBL interactions | MYC IPO5 KIF23 TUT4 RPS5 DHX57 RPS23 URB1 MKI67 PAN2 UTP20 DHX29 SLX4 | 1.72e-04 | 639 | 125 | 13 | int:FBL |
| Interaction | CXXC1 interactions | 1.75e-04 | 132 | 125 | 6 | int:CXXC1 | |
| Interaction | CEBPB interactions | MYC IPO5 PNKP RPS5 KDM3B PSMC2 RELA RPS23 ANKHD1 DHX9 GMPS SF3B1 BRCA2 MKI67 ASPM NFYC EHMT1 CCT8 SMARCC2 ELL KPNB1 | 2.08e-04 | 1443 | 125 | 21 | int:CEBPB |
| GeneFamily | DEAH-box helicases | 7.49e-05 | 16 | 95 | 3 | 500 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 5.64e-04 | 7 | 95 | 2 | 1201 | |
| GeneFamily | Plexins | 9.60e-04 | 9 | 95 | 2 | 683 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 1.14e-03 | 87 | 95 | 4 | 372 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.67e-03 | 181 | 95 | 5 | 694 | |
| GeneFamily | Actins|Deafness associated genes | 2.98e-03 | 113 | 95 | 4 | 1152 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.96e-03 | 18 | 95 | 2 | 596 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC KIF23 TUT4 ZFYVE16 KDM3B MED13L CBLB GMPS KLF10 BRCA2 SOCS5 NFYC UTP20 N4BP1 WDFY3 VCL | 4.48e-06 | 856 | 128 | 16 | M4500 |
| Coexpression | GSE3982_DC_VS_MAC_DN | 6.53e-06 | 200 | 128 | 8 | M5460 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 8.73e-06 | 27 | 128 | 4 | M2483 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 1.01e-05 | 28 | 128 | 4 | MM1323 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP | 3.12e-05 | 181 | 128 | 7 | M6857 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-08 | 188 | 128 | 8 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.07e-07 | 197 | 128 | 8 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.31e-07 | 174 | 128 | 7 | 46cbb462173a684ceb9e680f9259dc3b133763f7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.36e-06 | 191 | 128 | 7 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-06 | 192 | 128 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.51e-06 | 194 | 128 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.73e-06 | 198 | 128 | 7 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.79e-06 | 199 | 128 | 7 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.79e-06 | 199 | 128 | 7 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.79e-06 | 199 | 128 | 7 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.79e-06 | 199 | 128 | 7 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | Non-neuronal|World / Primary Cells by Cluster | 1.79e-06 | 199 | 128 | 7 | 165d9de6cedc79e13bb6fa244e8898a5dacc54ff | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.85e-06 | 200 | 128 | 7 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-06 | 157 | 128 | 6 | 1ccb07a38d3fb606ee5fbc0437655f49baaaa62c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-06 | 160 | 128 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-06 | 160 | 128 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-06 | 165 | 128 | 6 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 168 | 128 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.23e-06 | 168 | 128 | 6 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.54e-06 | 169 | 128 | 6 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 171 | 128 | 6 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 171 | 128 | 6 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 177 | 128 | 6 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 178 | 128 | 6 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 178 | 128 | 6 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 178 | 128 | 6 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 179 | 128 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 180 | 128 | 6 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 181 | 128 | 6 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 1.55e-05 | 184 | 128 | 6 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.80e-05 | 189 | 128 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 189 | 128 | 6 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 191 | 128 | 6 | b85a0978dc1e8af4f49423f56dcfd52efce09ed1 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.97e-05 | 192 | 128 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 1.97e-05 | 192 | 128 | 6 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 193 | 128 | 6 | bec113472c40c0106a9427248cbcf54548797596 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 193 | 128 | 6 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 194 | 128 | 6 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 194 | 128 | 6 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 194 | 128 | 6 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-05 | 195 | 128 | 6 | c6e31038be2463f1601d52c82efa4e9facb8228f | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.15e-05 | 195 | 128 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 196 | 128 | 6 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.21e-05 | 196 | 128 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-05 | 197 | 128 | 6 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-05 | 197 | 128 | 6 | 25bbe270d0897b9b1bd00d205f66efd1def81b99 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 198 | 128 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 2.34e-05 | 198 | 128 | 6 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.41e-05 | 199 | 128 | 6 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.41e-05 | 199 | 128 | 6 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 199 | 128 | 6 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.41e-05 | 199 | 128 | 6 | fa698f00d2dad74d28b4696c8c23dce70f123e52 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-05 | 199 | 128 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.41e-05 | 199 | 128 | 6 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-05 | 199 | 128 | 6 | f0c289523957258d16135c04679db379d43d28d9 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 2.47e-05 | 200 | 128 | 6 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 200 | 128 | 6 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-05 | 200 | 128 | 6 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 200 | 128 | 6 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 128 | 6 | 9279415f5e76cb5b4e071c6582ac249b72dd694c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 128 | 6 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 128 | 6 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating-Cycling|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 128 | 6 | d582385b2dbb25eeba1b22c5d258a8f26a40ef8b | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 2.47e-05 | 200 | 128 | 6 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-05 | 200 | 128 | 6 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | severe-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-05 | 200 | 128 | 6 | d341f4e500377a5bef82c24bf64704b981053336 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 200 | 128 | 6 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | LAM-Myeloid-pMacrophage|LAM / Condition, Lineage and Cell class | 2.47e-05 | 200 | 128 | 6 | 7e233d037165c9d3607604aaaf0f368e266567d3 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.47e-05 | 200 | 128 | 6 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.47e-05 | 200 | 128 | 6 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 2.47e-05 | 200 | 128 | 6 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 2.47e-05 | 200 | 128 | 6 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia|World / Primary Cells by Cluster | 2.47e-05 | 200 | 128 | 6 | ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 200 | 128 | 6 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.47e-05 | 200 | 128 | 6 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 200 | 128 | 6 | 5b014c658eecc5e73679e5feb7a2aaa3d297001d | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 134 | 128 | 5 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 4.93e-05 | 138 | 128 | 5 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 146 | 128 | 5 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 163 | 128 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 163 | 128 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 164 | 128 | 5 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 165 | 128 | 5 | 0ae39c9a6d1265d65dc0660924612cfe11e489ec | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 165 | 128 | 5 | 686cf89077cc7b744a6127de2b34d8c27da8b6c4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 165 | 128 | 5 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-04 | 165 | 128 | 5 | a5ed8c331d5551cd8bce50bdc31cb893218317cd | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 168 | 128 | 5 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 169 | 128 | 5 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 169 | 128 | 5 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 169 | 128 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 169 | 128 | 5 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 169 | 128 | 5 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.32e-04 | 170 | 128 | 5 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.36e-04 | 171 | 128 | 5 | 61d622153b91702ef21b0efc7b9581e592b7ccea | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 171 | 128 | 5 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.36e-04 | 171 | 128 | 5 | 09b3fa120f63c411f8a0dd6bd230a9720ce83fb1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 171 | 128 | 5 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 171 | 128 | 5 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 173 | 128 | 5 | 28c98a9a54aa2cfa67464db4f628c9357ad185b9 | |
| Drug | Sulfur Dioxide | 7.42e-07 | 58 | 124 | 6 | ctd:D013458 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 3.90e-06 | 8 | 123 | 3 | DOID:3891 (biomarker_via_orthology) | |
| Disease | Childhood Medulloblastoma | 3.13e-05 | 43 | 123 | 4 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.13e-05 | 43 | 123 | 4 | C1275668 | |
| Disease | Medullomyoblastoma | 3.13e-05 | 43 | 123 | 4 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.13e-05 | 43 | 123 | 4 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.13e-05 | 43 | 123 | 4 | C0278876 | |
| Disease | leiomyoma (implicated_via_orthology) | 5.16e-05 | 3 | 123 | 2 | DOID:127 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 5.71e-05 | 50 | 123 | 4 | C0025149 | |
| Disease | skin hydration measurement | 8.90e-05 | 21 | 123 | 3 | EFO_0009586 | |
| Disease | methylmalonate (MMA) measurement | 1.03e-04 | 4 | 123 | 2 | EFO_0800622 | |
| Disease | Huntington's disease (is_implicated_in) | 1.18e-04 | 23 | 123 | 3 | DOID:12858 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 1.37e-04 | 268 | 123 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.80e-04 | 67 | 123 | 4 | C3463824 | |
| Disease | ovarian neoplasm | 2.52e-04 | 134 | 123 | 5 | C0919267 | |
| Disease | Malignant neoplasm of ovary | 2.79e-04 | 137 | 123 | 5 | C1140680 | |
| Disease | ductal carcinoma in situ (is_implicated_in) | 3.57e-04 | 7 | 123 | 2 | DOID:0060074 (is_implicated_in) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.75e-04 | 8 | 123 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 6.30e-04 | 93 | 123 | 4 | C1535926 | |
| Disease | Leukemia, Myelocytic, Acute | 8.09e-04 | 173 | 123 | 5 | C0023467 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 8.83e-04 | 45 | 123 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 9.25e-04 | 11 | 123 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 9.25e-04 | 11 | 123 | 2 | DOID:8725 (is_marker_for) | |
| Disease | unipolar depression, multiple sclerosis | 1.11e-03 | 12 | 123 | 2 | EFO_0003761, MONDO_0005301 | |
| Disease | Schizophrenia | IPO5 DYM ITGA8 RELA SIRPB1 GRIN2A GRIN2B MDK PPARGC1A CSF2RA PTPRZ1 | 1.19e-03 | 883 | 123 | 11 | C0036341 |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.27e-03 | 51 | 123 | 3 | cv:CN043650 | |
| Disease | Fanconi anemia | 1.52e-03 | 14 | 123 | 2 | cv:C0015625 | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 1.52e-03 | 14 | 123 | 2 | DOID:898 (is_marker_for) | |
| Disease | Chronic Lymphocytic Leukemia | 1.58e-03 | 55 | 123 | 3 | C0023434 | |
| Disease | Hypertrophic Cardiomyopathy | 1.76e-03 | 57 | 123 | 3 | C0007194 | |
| Disease | age-related hearing impairment | 2.43e-03 | 324 | 123 | 6 | EFO_0005782 | |
| Disease | Bone marrow hypocellularity | 2.52e-03 | 18 | 123 | 2 | C1855710 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 2.67e-03 | 66 | 123 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | Colorectal Carcinoma | 2.76e-03 | 702 | 123 | 9 | C0009402 | |
| Disease | event free survival time, urinary bladder cancer | 2.81e-03 | 19 | 123 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | ascending aortic diameter | 2.85e-03 | 140 | 123 | 4 | EFO_0021787 | |
| Disease | bipolar I disorder | 2.92e-03 | 141 | 123 | 4 | EFO_0009963 | |
| Disease | Adenocarcinoma of prostate | 3.12e-03 | 20 | 123 | 2 | C0007112 | |
| Disease | estrogen-receptor negative breast cancer | 3.29e-03 | 71 | 123 | 3 | EFO_1000650 | |
| Disease | epilepsy (biomarker_via_orthology) | 3.44e-03 | 21 | 123 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Lewy Body Disease | 3.77e-03 | 22 | 123 | 2 | C0752347 | |
| Disease | Acute Lung Injury | 3.77e-03 | 22 | 123 | 2 | C0242488 | |
| Disease | Nonsyndromic genetic hearing loss | 3.98e-03 | 76 | 123 | 3 | cv:C5680182 | |
| Disease | autism spectrum disorder symptom | 4.12e-03 | 23 | 123 | 2 | EFO_0005426 | |
| Disease | spermatogenic failure (is_implicated_in) | 4.12e-03 | 23 | 123 | 2 | DOID:0111910 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQRLEINCQDPSIKT | 41 | Q8N9N5 | |
| SQLETSLKRLQCPQV | 121 | O43488 | |
| RVLVRKLCQPQSTGS | 286 | P55199 | |
| SRECNRQQKVIPVVN | 271 | Q96FG2 | |
| VRSQLETSLKRLQCP | 91 | Q8NHP1 | |
| IFVTKRNREVCTNPN | 66 | O15467 | |
| QRVRRAATPAAVTCQ | 26 | P07357 | |
| DIKSSVLRQVQVCPS | 41 | O94812 | |
| CETVREQLTNSIRKQ | 331 | Q9Y2D8 | |
| ERTERIKNCLNPQFS | 46 | O75131 | |
| QVRIVSENPQREACS | 386 | Q4G176 | |
| PQQRVTGAICVNSKE | 61 | Q9UKU9 | |
| QTCQNKAQVRSTRPQ | 366 | Q9UBZ4 | |
| VCTQPRRISAVSLAN | 626 | Q7Z478 | |
| VSQKVDRVRSPLQAC | 181 | Q8IZT6 | |
| INKTSSTRIPEQRFC | 221 | Q9UBL0 | |
| CTRSIQIPANRSKTA | 1561 | Q7Z401 | |
| KLNRRRQQQTPSSCS | 186 | A6NK89 | |
| RNVCVQTDRETFLKP | 801 | Q68DA7 | |
| RQTCPATITAKNRPQ | 416 | Q9H0B3 | |
| QVGECRRVQQLTLSP | 1126 | Q6DT37 | |
| QILRTCSRDPTQAIA | 446 | Q08999 | |
| VVKTRFQIQRCATDP | 36 | Q9BQT8 | |
| TCEKYQPTIQTRNIR | 721 | Q504Q3 | |
| SQKASCRISQRRNLP | 226 | Q9H649 | |
| RKERSPQQNIVSCVS | 196 | Q8NEZ4 | |
| LETCVVNIALPNRSR | 1851 | Q71F56 | |
| PCKTGQLQTNRARAT | 476 | Q8TC57 | |
| SKQNIRRDCNPEVSE | 261 | Q6ZRS4 | |
| QKLSQQQESVCPRES | 1526 | Q6PRD1 | |
| QRICNAITKSHPQRS | 311 | Q9NXD2 | |
| RYNAQCQETIRVTKP | 111 | P21741 | |
| PLQLTCRQDQRAVAV | 426 | Q96KR4 | |
| NVRKCTDRQNSPVTS | 466 | Q13191 | |
| RPQQVRKQCGQDSRT | 266 | A6NNH2 | |
| LSKCVQVRVRPNNVS | 536 | P51805 | |
| SSRELCQNKSQPNRT | 541 | O60486 | |
| QPLTRSLSEKNRCDQ | 466 | Q9H706 | |
| CISRQNKSVLRPAVT | 1126 | Q7LBC6 | |
| PNNCSGVRKRRLSNV | 201 | O94806 | |
| VLCSVQSPRKVLQEV | 146 | Q6UX53 | |
| RRQCIRENGNVAKTP | 831 | P46013 | |
| QCNREKNRTSSIIPV | 2046 | P23471 | |
| PCAKRLANVVRQVQT | 1056 | O00410 | |
| KPQSIQRDIITVCND | 191 | Q0VAM2 | |
| CRQIPFDTTNNRKIR | 106 | P53708 | |
| PRRCLKETLQITQTE | 286 | Q13952 | |
| RQVRVQESSCPLAQQ | 2031 | Q7Z442 | |
| PCSTRKQLQDQEIRA | 446 | Q9UBK2 | |
| SQKKLRTRTISNCPN | 101 | Q3MJ16 | |
| SQATRQEPCTQVRTR | 446 | Q8N878 | |
| ITCDVNIVVRPISNK | 3391 | Q4G0P3 | |
| QKQPSCQRSVVIRTF | 626 | P49915 | |
| TCVPFRTTKERQEIQ | 2331 | P51587 | |
| SNQQIRQTCVRKSLI | 176 | Q86V35 | |
| ATISVCRSLVENNPR | 56 | Q7RTS9 | |
| PRSKVTQCSQNTKRS | 1616 | Q8WZ74 | |
| EKVANIICTQPRRIS | 591 | Q6P158 | |
| NPESEKRNTCVLREQ | 281 | Q96PZ2 | |
| QVCVSPTVNQRLKDS | 406 | Q16850 | |
| REQQSRVVKCSANPI | 271 | B7Z1M9 | |
| QPSQCRFQTLRLPTK | 361 | Q96DP5 | |
| KSQEITTNSEQRCPL | 126 | Q99741 | |
| TQCPDTRVRVAALQN | 226 | Q14974 | |
| SPNRSKCERNTVADV | 206 | Q13118 | |
| APKRQASCILNVQSR | 41 | Q96QF7 | |
| TLRRNTPCSIKNQLG | 951 | Q9NRM1 | |
| NLLPTKATDRENRCQ | 96 | P05305 | |
| TPKSREITTLANNQC | 526 | Q9H9B1 | |
| CNQSPVRQVLNITDK | 556 | P22223 | |
| KQAENICRQATIQPR | 86 | Q8N815 | |
| KNRVVEPRLSNNECS | 66 | P15509 | |
| AECNIVVTQPRRISA | 436 | Q08211 | |
| TLSLPDQQTGKCRRV | 76 | Q6PF18 | |
| ARRRQQEPGQSKTCI | 746 | Q02241 | |
| QEPGQSKTCIVSDRR | 751 | Q02241 | |
| NIQSVPKCSENERTQ | 1216 | P56715 | |
| RCLQVPEISTQRKVN | 86 | A6NES4 | |
| TPSQCVVARTLGKQQ | 581 | Q96J94 | |
| LTPAKRARQQETQLC | 266 | Q6ZR62 | |
| TLQSEQPLQVARCTK | 86 | P35998 | |
| FRKAQCPIVERLTNS | 61 | P46782 | |
| QSEPARVQCRQVFLK | 2256 | O75691 | |
| KLRNRVVPGCVTQSQ | 251 | P49683 | |
| RTNPDLIIVCAQSSQ | 666 | Q9UPR3 | |
| SRRNQNCATEIPQIV | 76 | O75159 | |
| CNTKLLSNEIRNIPR | 1621 | B5MCY1 | |
| ITNLRVQLLKRQSCP | 221 | Q9HB63 | |
| RVLRQISNNRKCTSP | 331 | P01106 | |
| GPLTQVTDRKCSRTQ | 36 | Q96T60 | |
| TRQPKKQVSSPCAQR | 591 | Q6NSI8 | |
| TIEKSLVQNNCLSRP | 126 | Q8TAQ2 | |
| SQRLCQPSSQEPAKR | 1896 | O60287 | |
| RTCIQQNIPRSSSTQ | 816 | Q9H2D6 | |
| SPRVAKTQQKRRNCS | 286 | Q5VYV7 | |
| TPIRGSCTTQRKLQE | 1476 | Q8IY92 | |
| PVRAENQVNVTCQVR | 261 | Q5TFQ8 | |
| AQTETCTVAPRERQN | 26 | P04155 | |
| QLCVTNTRTPSSVRK | 1946 | Q8IWZ3 | |
| ERQQNRPSVITCASA | 156 | Q14135 | |
| IKTRGQQATLRCSPI | 31 | A0A5A2 | |
| QQVLCQRRTSPKPFT | 391 | P48736 | |
| FPKRETVCLLSQNQV | 706 | O75443 | |
| QPNSAIRKCVRVQLI | 61 | P62266 | |
| IKTRGQQVTLRCSPI | 31 | A0A597 | |
| RPNVTTCRQVGKTLR | 36 | Q9Y228 | |
| IAECSNRRLQEVPQT | 46 | Q9NR97 | |
| STPNVVSQQACTRDR | 181 | Q96MU6 | |
| NLQVSVPVISCRSKQ | 1791 | Q8IZQ1 | |
| LKVQERQNRVCTTVA | 1101 | O75533 | |
| SQKRPRCSATAQRVA | 756 | Q96HA7 | |
| PCKQRISVQRESQSR | 66 | Q96SQ5 | |
| RRPVKTSTCQKAQVR | 286 | Q8WWF5 | |
| RTNLLQVCERIPTIS | 1046 | P18206 | |
| PCKQRISVQRESQSR | 66 | Q8TAU3 | |
| REETRNLTPKQCAVL | 1341 | O14795 | |
| PQNVLENCRSHTEKR | 196 | Q96RU2 | |
| SAVISQKPSRDICQR | 16 | A0A5B7 | |
| SVQRCSVVVSQPNKE | 1141 | Q9ULL1 | |
| ECPEVKLARQRNSSV | 1371 | Q5TAX3 | |
| RNIQACKELAQTTRT | 31 | P50990 | |
| NRAPNTAELKICRVN | 186 | Q04206 | |
| QNRIQCAIKSLSRIT | 1106 | Q04912 | |
| IKTRGQQVTLRCSPI | 31 | A0A0A0MS03 | |
| QRTSLLPKDQECVNS | 51 | Q7Z3T8 | |
| KCTVSVETRLNQPQP | 976 | O94832 | |
| KPINRRVSSQQCLSG | 1466 | Q8NEV4 | |
| SNCRINTFRTVPIEQ | 456 | O75113 | |
| KQSSIIIQPRQCTEQ | 36 | Q9UBF9 | |
| IIQPRQCTEQRFSAS | 41 | Q9UBF9 | |
| RNTVPCRKFVKINNS | 431 | Q12879 | |
| RNTVPCQKRIVTENK | 431 | Q13224 |